GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...

Compounded tirzepatide is a formulation of tirzepatide that’s been changed in some way from the FDA-approved versions of the drug. Compounding can include adding extra ingredients, removing ...

Many patients looking to save money are buying compounded tirzepatide instead of Mounjaro and Zepbound. But an FDA decision could put an end to that. The U.S. Food and Drug Administration (FDA ...

The Food and Drug Administration said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs ...

She takes a compounded version of tirzepatide, Eli Lilly's drug sold under the name Mounjaro to treat diabetes and Zepbound for weight loss. The average retail price for Zepbound is nearly $1,300 ...

The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely ...

If tirzepatide remains off the FDA's drug shortage list, compounding pharmacies must cease the production of these medications on any significant scale, according to gastroenterologist and obesity ...

On October 3, 2024, the US Food and Drug ... compounding pharmacies will generally no longer be able to rely on the FDA shortage list exception for compounding “essentially copies” of ...

The Food and Drug Administration said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide — the active ingredient in Eli Lilly’s ...